Who invested in QurAlis?
QurAlis's investors include Polaris Partners, Alexandria Venture Investments, Sanofi, EQT Life Sciences and Mission BioCapital, and 4 more on record.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$94Mraised across 2 rounds since 2018, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $60M sold, first sale Dec 2022
Reported by FinSMEs
From QurAlis's own website: 7 on the team.
AdvisersAmmar Al-ChalabiSudhir Agrawal
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
QurAlis's investors include Polaris Partners, Alexandria Venture Investments, Sanofi, EQT Life Sciences and Mission BioCapital, and 4 more on record.
QurAlis has raised $94M across 2 rounds since 2018.
QurAlis's most recent round was a Series B of $88M in Mar 2023.
Its most recent round, $88M in Mar 2023, is also its largest on record.
QurAlis's first round on record, in Nov 2018, was backed by Amgen, MP Healthcare Venture Management and BioInnovation Capital and 1 others.
QurAlis's latest named round is a Series B, in Mar 2023.
QurAlis is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.